Concepedia

Brad Roadcap

BR

Statistics

Publications

13

Citations

723

H-Index

12

Active since

2000

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Clinical Research Associates

Brad Roadcap is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and mass spectrometry.

ORCID

Top concepts

Publications per year

2000–2024

13

Publications

13

Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins

Thomayant Prueksaritanont, Jamie J. Zhao, Bennett Ma et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 288 citations

Quantitation of simvastatin and its ?-hydroxy acid in human plasma by liquid-liquid cartridge extraction and liquid chromatography/tandem mass spectrometry

Jamie J. Zhao, Iris Xie, Amy Y. Yang et al. · Journal of Mass Spectrometry · 2000 · 82 citations

, , +18

A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK‐1654 in Healthy Adults

Antonios O. Aliprantis, Dennis Wolford, Luzelena Caro et al. · Clinical Pharmacology in Drug Development · 2020 · 61 citations

Interactions between Simvastatin and Troglitazone or Pioglitazone in Healthy Subjects

Thomayant Prueksaritanont, José María Guerrero Vega, Jamie J. Zhao et al. · The Journal of Clinical Pharmacology · 2001 · 55 citations

Assessment of the CYP3A‐Mediated Drug Interaction Potential of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Volunteers

Rajesh Krishna, Arthur Bergman, Bo Jin et al. · The Journal of Clinical Pharmacology · 2008 · 38 citations

1–5 of 13